Product Information

FT CHEST CONG RLF PE 400-10 MG is a generic product labeled by Strategic Sourcing Services LLC, priced at $0.0924 per EA under NDC 70677105601. Its NADAC has been published 168 times since Sep 6, 2023.

FT CHEST CONG RLF PE 400-10 MG

Guaifenesin/phenylephrine
$0.0924per EA
OTC

Strength

400; 10 mg/1; mg/1

NDC

70677105601

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

11/18/2026

Approval Type

OTC MONOGRAPH DRUG

FDA Application

M012

On Market Since

1/27/2023

Pharmacological Classes

Adrenergic alpha1-Agonists
Decreased Respiratory Secretion Viscosity
Expectorant
Increased Respiratory Secretions
alpha-1 Adrenergic Agonist

Price Statistics

The NADAC for FT CHEST CONG RLF PE 400-10 MG has been published 168 times since Sep 6, 2023, and over the history we have for it it has risen 13.6%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0924 per EA
All-time high$0.0927 (Nov 11, 2026)
All-time low$0.0740 (Feb 18, 2026)
52-week high$0.0927
52-week low$0.0740
Median price$0.0829
Average price$0.0833
Largest weekly change+10.0% (Dec 20, 2023)
Weeks tracked168
Tracking sinceSep 6, 2023

Price History

1W

-0.4%

1M

+1.0%

3M

+2.3%

6M

+6.0%

1Y

+17.5%

3Y

+9.9%

5Y

N/A

All

+13.6%

Generic Alternatives

The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 25% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of FT CHEST CONG RLF PE 400-10 MG?

The current National Average Drug Acquisition Cost (NADAC) for FT CHEST CONG RLF PE 400-10 MG, manufactured by Strategic Sourcing Services LLC, is $0.0924 per EA (NDC 70677105601), effective Nov 18, 2026.

How has the price of FT CHEST CONG RLF PE 400-10 MG changed over time?

Over the history we have for it, the NADAC for FT CHEST CONG RLF PE 400-10 MG has risen 13.6%. It has been tracked across 168 weekly CMS publications since Sep 6, 2023.

What are the highest and lowest recorded NADAC prices for FT CHEST CONG RLF PE 400-10 MG?

Since Sep 6, 2023, the NADAC for FT CHEST CONG RLF PE 400-10 MG has ranged from a low of $0.0740 (Feb 18, 2026) to a high of $0.0927 (Nov 11, 2026), with a median of $0.0829 per EA.

Are there cheaper alternatives to FT CHEST CONG RLF PE 400-10 MG?

Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, SM CHEST CONG RELIEF PE CAPLET, is $0.0697 per EA — about 25% below FT CHEST CONG RLF PE 400-10 MG.

Who manufactures FT CHEST CONG RLF PE 400-10 MG?

FT CHEST CONG RLF PE 400-10 MG (NDC 70677105601) is labeled by Strategic Sourcing Services LLC, and CMS classifies it as a generic product.